F. Perry Wilson, MD, MSCE, shares insights from a review of recent study results published in the New England Journal of Medicine examining duty-hours rules at 63 residency…
NEW YORK (Reuters Health) – A large study of revascularization strategies in diabetics with multivessel coronary artery disease, which set out to show that angioplasty is not inferior…
NEW YORK (Reuters Health) – Continuing to take low-dose aspirin after endoscopic treatment of a bleeding peptic ulcer raises the risk for re-bleeding but may also reduce mortality…
NEW YORK (Reuters Health) – Giving intravenous drugs during out-of-hospital cardiac arrest does not improve survival, according to a study in the Journal of the American Medical Association…
NEW YORK (Reuters Health) – Adding cetuximab to standard chemotherapy for colorectal liver metastases often shrinks inoperable lesions enough to permit resection, according to a study released today…
NEW YORK (Reuters Health) – Systolic blood pressure, left ventricular (LV) mass, and diabetes status independently predict the likelihood that prehypertensive patients with cardiac risk factors will develop…
NEW YORK (Reuters Health) – Transradial percutaneous coronary intervention (PCI) for acute MI is associated with a lower risk of major bleeding and other adverse events than transfemoral…
NEW YORK (Reuters Health) – Treating HER-2 positive, metastatic breast cancer with trastuzumab significantly increased survival in a retrospective study, to the point were such women given the…
NEW YORK (Reuters Health) – In patients receiving glucocorticoids for inflammatory diseases, adverse events are very common, even at low to medium doses, according to a meta-analysis by…
NEW YORK (Reuters Health) – Interruption of cardiopulmonary resuscitation (CPR) compressions is common and prolonged when paramedics attempt to perform endotracheal intubation at the same time, research indicates.…
NEW YORK (Reuters Health) – An “important” relation exists between platelet reactivity and glycemic control in patients with type 2 diabetes and coronary artery disease who are on…
